icon-folder.gif   Conference Reports for NATAP  
 
  Reported by Jules Levin
IDWeek Oct 26-30
New Orleans 2016
Back grey_arrow_rt.gif
 
 
 
Efficacy of Dolutegravir/Abacavir/Lamivudine (ABC/DTG/3TC) Fixed Dose Combination (FDC) compared with Ritonavir Boosted Atazanavir (ATV/r) plus Tenofovir Disoproxil Fumarate/Emtricitabine (TDF/FTC) in Treatment-Na´ve Women with HIV-1 Infection (ARIA Study): Analyses by Race Subgroups
 
 
  Reported by Jules Levin
IDWeek 2016 Oct 26-30 New Orleans
 
Debbie Hagins, MD1, Craig Dietz, MD2, Mamta Jain, MD3, Cornelius Van Dam, MD4, Indira Brar, MD5, Choy Man, BSc6, Jiangxiu Zhou, PhD7, Annie Buchanan, MD, MPH6, Brian Wynne, MD8, Cindy Vavro, BA6, Michael Aboud, MD9 and Kimberly Smith, MD6

HIV1

HIV2

HIV3

HIV4

HIV5

HIV6

HIV7